FDA Approves Unknown Drug — MACLEODS PHARMS
The FDA has approved Macleods Pharmaceuticals’ Abbreviated New Drug Application (ANDA 206885), signaling a potential entry into the market through the submission of a tentative approval that will provide an important strategic impetus for the company’s generic portfolio.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed